Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know-Reference-Cited by-同舟云学术

Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know

Published:2021-01 Issue:1 Volume:13 Page:
ISSN:2352-8729
Container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
language:en
Short-container-title:Alz & Dem Diag Ass & Dis Mo

Author:

Erickson Claire M.¹²,Chin Nathaniel A.²,Johnson Sterling C.²³⁴,Gleason Carey E.²⁴,Clark Lindsay R.²³⁴

Affiliation:

1. Neuroscience & Public Policy Program University of Wisconsin‐Madison School of Medicine and Public Health Madison Wisconsin USA

2. Alzheimer's Disease Research Center University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA

3. Wisconsin Alzheimer's Institute University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA

4. Geriatric Research Education and Clinical Center William S. Middleton Memorial Veterans Hospital Madison Wisconsin USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

Reference50 articles.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献